CYSTADROPS

Drug RECORDATI_RARE_DISEASES_INC.
Total Payments
$53,811
Transactions
200
Doctors
162
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $50,650 74 59
2023 $2,477 90 80
2022 $684.66 36 35

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $25,000 1 46.5%
Honoraria $17,345 6 32.2%
Food and Beverage $7,616 184 14.2%
Travel and Lodging $2,820 8 5.2%
Consulting Fee $1,030 1 1.9%

Payments by Type

General
$28,811
199 transactions
Research
$25,000
1 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Donald Suh at The Regents of the University of California on Assessment and Improvement of Treatment for Corneal Involvement in Cystinosis RECORDATI_RARE_DISEASES_INC. $25,000 1

Top Doctors Receiving Payments for CYSTADROPS

Doctor Specialty Location Total Records
, MD Ophthalmology Marshalltown, IA $26,613 4
, MD Ophthalmology Cleveland, OH $19,768 14
, M.D Ophthalmology Peachtree Corners, GA $168.73 1
, OD Optometrist Peachtree Corners, GA $168.73 1
, M.D Ophthalmology Tulsa, OK $164.51 3
, STUDENT Optometrist Tulsa, OK $124.97 1
, MD, MS Ophthalmology Bayside, NY $122.19 1
, MD Ophthalmology New Hyde Park, NY $122.19 1
, MD Ophthalmology Plainview, NY $122.19 1
, M.D Ophthalmology Bay Shore, NY $122.19 1
, MD Ophthalmology Great Neck, NY $122.19 1
, M.D Ophthalmology New Hyde Park, NY $122.19 1
, M.D Retina Specialist Great Neck, NY $122.19 1
, MD Ophthalmology Glendale, NY $122.19 1
, MD Ophthalmology Jamaica, NY $122.19 1
, MD Ophthalmology Levittown, NY $122.19 1
, MD Ophthalmology Riverhead, NY $122.19 1
, M.D Ophthalmology Wantagh, NY $122.19 1
, M.D Ophthalmology Manhasset, NY $122.19 1
, M.D Ophthalmology Hicksville, NY $122.19 1
, M.D Ophthalmology Glen Cove, NY $122.19 1
, MD Ophthalmology Garden City, NY $122.19 1
, M.D Ophthalmology Garden City, NY $122.19 1
, MD Ophthalmology Great Neck, NY $122.19 1
, M.D Ophthalmology Bayside, NY $122.19 1

About CYSTADROPS

CYSTADROPS is a drug associated with $53,811 in payments to 162 healthcare providers, recorded across 200 transactions in the CMS Open Payments database. The primary manufacturer is RECORDATI_RARE_DISEASES_INC..

Payment data is available from 2022 to 2024. In 2024, $50,650 was paid across 74 transactions to 59 doctors.

The most common payment nature for CYSTADROPS is "Unspecified" ($25,000, 46.5% of total).

CYSTADROPS is associated with 1 research study, including "Donald Suh at The Regents of the University of California on Assessment and Improvement of Treatment for Corneal Involvement in Cystinosis" ($25,000).